Session Type
Meeting
Search Results for Morbidity
Abstract Number: 28
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: This is an exciting time for Telemedicine with new programs being implemented across the continuum of care including acute care, post-acute care, and in home settings. Proving the value of telemedicine programs when no access to providers exist is relatively straightforward but proving value of programs where implemented to augment existing care by the […]
Abstract Number: 47
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: The Charlson comorbidity index (CCI) has been one of the most commonly used and validated prognostication tools. In addition to being a valuable resource for health services researchers, the CCI is being used in clinical practice by hospitals to identify patients at risk for poor outcomes. The use of the CCI in older adults […]
Abstract Number: 73
SHM Converge 2023
Background: Ascorbic acid (AA) deficiency affects disproportionally the older population. The recognition of AA deficiency is elusive since we do not measure AA routinely. We assessed the influence of AA supplementation on hospitalization outcomes for community geriatric patients. Methods: Single-center, retrospective study of community-dwelling patients older than 65-years old admitted to a community hospital from […]
Abstract Number: 74
SHM Converge 2023
Background: Most cases of pneumonia in older people are aspiration pneumonia,[1] and the prognosis among patients hospitalized for aspiration pneumonia is very poor.[2] After being hospitalized for aspiration pneumonia, a certain number of patients become unable to take orally, and some chronic conditions are reported to be negatively associated with the retrievement of oral intake.[3] […]
Abstract Number: 86
SHM Converge 2021
Background: The number of survivors of an initial COVID-19 disease hospitalization is growing and further data describing clinical and sociodemographic risk factors for hospital readmissions is needed. The CROSS (COVID-19 Characteristics of Readmissions and Outcomes and Social Determinants of Health Study) Collaborative was developed in July 2020 and is a multidisciplinary, multi-hospital group dedicated to […]
Abstract Number: 118
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: In the primary care setting, up to one third of patients are categorized as complex, while this proportion is not well known in the hospital setting. By definition, complex patients demand more effort and/or resources and required care processes are not routine or standard. The treating physician’s complexity assessment is the gold standard, which […]
Abstract Number: 132
SHM Converge 2024
Background: High need patients are characterized by medical complexity, high amounts of health acute care utilization and disproportionate costs[1]. Recent studies have characterized worsening of loneliness in the general population, however, it has not been characterized in the high need population. We hypothesized that increases in loneliness would be associated with increasing symptoms of depression; […]
Abstract Number: 136
SHM Converge 2023
Background: The underlying burden of medical co-morbidity is often the main driver of ICU transfer of patients initially admitted to the medical wards (1). The role of non-patient related factors is unclear, as are the mortality and economic data associated with ICU transfer from the medical ward. The purpose of this analysis was to identify […]
Abstract Number: 137
SHM Converge 2024
Background: Despite having the highest health care spending, the US continues to have rates of maternal mortality over three times greater than similarly high-income countries. Generally, deaths occur in the days immediately following birth, and typically occur in hospital intensive care units (ICUs). As ICU utilization is often employed to identify indication of severe maternal […]
Abstract Number: 164
Hospital Medicine 2020, Virtual Competition
Background: The risk for serious infections and poor treatment outcomes is reported to be higher in patients with diabetes compared to the general population. Omadacycline (OMC) is an intravenous (IV) and oral aminomethylcycline antibiotic approved in the US to treat acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) in adults. […]